Sangamo Therapeutics Inc (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 116,291 | 171,222 | 80,968 | 140,418 | 39,298 |
| Marketable Securities | 240,561 | 271,877 | 270,028 | 259,715 | 419,272 |
| Receivables | 22,633 | 12,861 | 7,905 | 5,048 | 6,250 |
| TOTAL | $384,176 | $461,808 | $362,628 | $410,521 | $468,202 |
| Non-Current Assets | |||||
| PPE Net | 26,516 | 21,019 | 18,281 | 78,723 | 50,497 |
| Investments And Advances | 52,789 | 8,450 | 0 | 0 | 0 |
| Intangibles | 90,011 | 93,687 | 92,453 | 94,287 | 1,585 |
| Other Non-Current Assets | 86,730 | 88,517 | 69,367 | 6,864 | 86,320 |
| TOTAL | $256,046 | $211,673 | $180,101 | $179,874 | $138,402 |
| Total Assets | $640,222 | $673,481 | $542,729 | $590,395 | $606,604 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 21,965 | 22,505 | 30,135 | 21,457 | 16,424 |
| Accrued Expenses | 11,024 | 8,714 | 6,168 | 9,490 | 6,605 |
| TOTAL | $80,550 | $82,045 | $91,127 | $78,511 | $74,123 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 47,561 | 50,826 | 54,824 | 47,564 | 51,094 |
| Other Non-Current Liabilities | 46,205 | 44,910 | 15,263 | 1,960 | 1,730 |
| TOTAL | $140,344 | $145,688 | $122,421 | $144,627 | $152,575 |
| Total Liabilities | $220,894 | $227,733 | $213,548 | $223,138 | $226,698 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 115,938 | 115,675 | 115,362 | 102,273 | 102,093 |
| Common Shares | 1,158 | 1,156 | 1,023 | 1,022 | 1,018 |
| Retained earnings | -661,540 | -634,233 | -603,949 | -562,696 | -544,032 |
| Other shareholders' equity | -4,662 | -151 | -2,005 | -701 | -244 |
| TOTAL | $419,328 | $445,748 | $329,181 | $367,257 | $379,906 |
| Total Liabilities And Equity | $640,222 | $673,481 | $542,729 | $590,395 | $606,604 |